Stock listing
NASDAQ:IMPL Impel Neuropharma Inc Stock
Follow Impel Neuropharma Inc into a list and get an email when it puts out news.
Delisted NASDAQ:IMPL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:IMPL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John Leaman Other companies: Traws Pharma, Inc. (Director · Since at least Oct 1, 2025); Cartesian Therapeutics, Inc. (CFO, Treas. & Hd Corp Strategy · Oct 26, 2017 – Jun 15, 2018 · Past) | Chief Fin. & Business Officer · Apr 22, 2021 – Jan 26, 2022 · Past |
| John Hoekman | Chief Scientific Officer · Apr 22, 2021 – Jan 26, 2022 · Past |
| Leonard Paolillo | Chief Commercial Officer · Apr 22, 2021 – Jan 26, 2022 · Past |
| Stephen B Shrewsbury | Chief Medical Officer · Apr 22, 2021 – Mar 29, 2022 · Past |
Log in to ask 6ix AI your own questions about Impel Neuropharma Inc.